Sleep Disorder Market is projected to grow substantially between 2023-2032 owing to the increasing global incidences of sleep disorders such as narcolepsy, restless legs syndrome, insomnia, and sleep apnea. These disorders are impacting every aspect of life, including safety, thinking, mental health, school, work performance, weight, and the development of diabetes and heart disease. According to credible reports, approximately 70 million people suffer from sleep disorders in the United States.
Get sample copy of this research report @ https://www.gminsights.com/request-sample/detail/5172
Furthermore, the industry is likely to demonstrate a positive trajectory owing to the availability of insurance coverage for treating sleep apnea and other sleep disorders. The costs covered by health insurance have encouraged people to address and treat such conditions effectively, thereby positively surging product demand across the globe.
Overall, the sleep disorder industry is segmented in terms of disorder, product, end-use, and region.
Based on disorder, the restless legs syndrome (RLS) segment is anticipated to exhibit over 12% CAGR through 2032. The increasing prevalence of restless legs syndrome, along with constant technological advancements, will positively influence the segmental expansion. As per reports, sleep disorder affects 5-10% of American adults and 2%-4% of children in the country.
By product, the diagnostics segment will depict considerable growth owing to the numerous advantages offered by diagnostic devices, such as precise disease diagnosis and assessment of treatment efficacy. Moreover, these devices are small, easy to use, and comprise a combined thermistor, nasal pressure transducer signals, a finger pulse oximeter, etc., which is anticipated to spur their adoption in the future.
In terms of end-use, sleep laboratories & hospitals will be in huge demand over the coming years. Increasing preference for sleep laboratories & hospitals for quality sleep disorders treatment and affordability will positively influence the segment growth. Besides, the high-quality services and increasing number of sleep disorder treatment procedures at sleep laboratories & hospitals are projected to boost the market growth.
In terms of the regional context, the Asia Pacific sleep disorder market is estimated to exhibit over 13.5% CAGR through 2032. The influx of venture capital, rising utilization of sleep disorder devices, and encouraging government initiatives are key factors driving the demand for sleep disorder treatment across the region, especially in countries such as China and India.
Request for customization @ https://www.gminsights.com/roc/5172
Table of Contents (ToC) of the report:
Chapter 1 Methodology & Scope
1.1 Industry coverage
1.2 Market scope & definitions
1.3 Base estimates & working
1.3.1 Data collection
1.4 Forecast parameters
1.5 COVID-19 impact analysis at global level
1.6 Data validation
1.7 Data sources
1.7.1 Primary
1.7.2 Secondary
1.7.2.1 Paid sources
1.7.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Sleep disorder industry 3600 synopsis, 2018 - 2032
2.1.1 Business trends
2.1.2 Disorder type trends
2.1.3 Product trends
2.1.4 End-use trends
2.1.5 Regional trends
Browse complete Table of Contents (ToC) of this research report @ https://www.gminsights.com/toc/detail/sleep-disorder-market
About Global Market Insights:
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.
Contact Us:
Aashit Tiwari
Corporate Sales, USA
Global Market Insights Inc.
Toll Free: 1-888-689-0688
USA: +1-302-846-7766
Europe: +44-742-759-8484
APAC: +65-3129-7718
Email:[email protected]
